{"id":"W3042176300","doi":"10.1016/j.kint.2020.06.024","title":"Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment","year":2020,"lang":"en","type":"article","venue":"Kidney International","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; McMaster University; Impact","funders":"National Heart, Lung, and Blood Institute; BERLIN-CHEMIE; Eli Lilly Australia; NIHR Leicester Biomedical Research Centre; GlaxoSmithKline; Hong Kong Government; Gilead Sciences; Servier; Fresenius Medical Care North America; Astellas Pharma; National Institutes of Health; Indian Council of Medical Research; Menarini Group; Novo Nordisk; National Institute for Health and Care Research; Alnylam Pharmaceuticals; Akebia Therapeutics; Steno Diabetes Center Copenhagen; Sanofi; Amgen; Pfizer; Eli Lilly and Company; AstraZeneca; Ironwood Pharmaceuticals, Incorporated","keywords":"Guideline; Medicine; Executive summary; Diabetes mellitus; Intensive care medicine; Kidney disease; MEDLINE; Diabetes management; Evidence-based practice; Internal medicine; Type 2 diabetes; Alternative medicine; Political science; Business; Pathology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01210125,0.001662526,0.002938249,0.00450822,0.0009033452,0.006516964,0.003772647,0.006362183,0.04982419],"category_scores_gemma":[0.05788282,0.0008677784,0.002750089,0.006590293,0.0006460946,0.003273088,0.002326333,0.007058049,0.04664602],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00447547,"about_ca_system_score_gemma":0.02004757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01550566,"about_ca_topic_score_gemma":0.01496902,"domain_scores_codex":[0.9902829,0.002858342,0.001952271,0.0004898892,0.003832509,0.0005840042],"domain_scores_gemma":[0.9605432,0.006753316,0.00461176,0.0005371778,0.02502787,0.002526717],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000238977,0.00001467803,0.0001102068,0.001459189,0.00001898737,0.00001917204,0.00001430079,0.0000705597,0.00001662484,0.0007581832,0.9574885,0.04000582],"study_design_scores_gemma":[0.0001298837,0.00003644445,0.00117257,0.01337447,0.00008994558,0.00006395364,0.00003996415,0.0001204584,0.00004348659,0.001414133,0.983492,0.00002274515],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.000714592,0.1842943,0.005992748,0.440529,0.09916221,0.005448131,0.08180089,0.0008741656,0.181184],"genre_scores_gemma":[0.007881314,0.392423,0.02288307,0.2353773,0.05537017,0.01293418,0.1487078,0.00110708,0.1233161],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.04982419,"threshold_uncertainty_score":0.1666785,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02443741152293822,"score_gpt":0.295710383380036,"score_spread":0.2712729718570978,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}